Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 60255C885 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Deep Track Capital, LP
13G/A
Amendment 2
|
6.9% |
11/14/2025
Event 9/30/2025
|
|
| Deep Track Capital, LP | 6.9% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 6.9% | ||
| David Kroin | 6.9% | ||
|
Deep Track Capital, LP
13G/A
Amendment 1
|
8.2% |
5/15/2025
Event 3/31/2025
|
|
| Deep Track Capital, LP | 8.2% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 8.2% | ||
| David Kroin | 8.2% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 8.3% |
2/5/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q1 | 1 | 17.0 k | $321 k |
| 2025 Q4 | 214 | 56.6 M | $758 M |
| 2025 Q3 | 214 | 39.8 M | $469 M |
| 2025 Q2 | 197 | 42.0 M | $272 M |
| 2025 Q1 | 205 | 41.2 M | $241 M |
| 2024 Q4 | 186 | 41.5 M | $289 M |
| 2024 Q3 | 172 | 49.5 M | $282 M |
| 2024 Q2 | 170 | 41.7 M | $301 M |
| 2024 Q1 | 154 | 35.0 M | $330 M |
| 2023 Q4 | 116 | 5.02 M | $18.4 M |
| 2023 Q3 | 102 | 3.88 M | $12.1 M |
| 2023 Q2 | 93 | 3.89 M | $13.9 M |
| 2023 Q1 | 97 | 3.96 M | $12.6 M |
| 2022 Q4 | 112 | 5.06 M | $11.1 M |
| 2022 Q3 | 107 | 3.77 M | $13.2 M |
| 2021 Q4 | 1 | 13.0 k | $18.0 k |
| 2021 Q2 | 1 | 140 k | $483 k |